Nvidia-backed Iambic Therapeutics raises $150M in IPO, begins trading Thursday
read at Endpoints ↗DealPositive
Iambic Therapeutics, a biotech focused on using artificial intelligence to develop cancer treatments, announced the completion of its initial public offering.
The company sold 9.38 million shares at $16 each, generating roughly $150 million in gross proceeds.
Backed by Nvidia, Iambic will start trading on the market on Thursday under the ticker $IAM.
The funding is intended to advance its AI-driven pipeline and support further research and development efforts.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Iambic snags $150M IPO for AI-driven cancer pipeline”
read at Endpoints ↗82 words · retrieved 50m ago
comments(0)
5-min edit window · permanent after that